0 item(s)
View cart
You have no items in your shopping cart.
01
Feb
Lymphocytic Choriomeningitis Virus (LCMV): Overview
Understanding the Pathogenesis, Clinical Manifestations, and Prevention
Lymphocytic choriomeningitis virus (LCMV) is a significant rodent-borne pathogen known for causing febrile illness and aseptic meningitis in humans. It serves as a critical model in neurovirology research and remains a focus of public health surveillance due to its unique zoonotic transmission profile.
01 Virological Characteristics
Taxonomic Classification
LCMV belongs to the Arenaviridae family. It is categorized into four lineages (I–IV), with lineages I–III being the primary contributors to human disease.
Transmission Path
The virus is hosted by house mice and wild mice. Infection occurs via contact with urine, feces, or saliva. Importantly, person-to-person transmission is extremely rare and generally not documented.
02 Clinical Manifestations
Human Symptoms (Incubation: 1–2 Weeks)
- Initial Phase: Fever, severe myalgia, and headache (flu-like).
- Complications: ~10% develop parotitis or orchitis.
Animal Manifestations
- Neurological: Tremors and CNS seizures.
- Visceral: Systemic involvement, notably hepatitis.
- Chronic: Immune-mediated conditions like glomerulonephritis.
Diagnosis & Management
Diagnosis: Confirmed through RT-PCR, ELISA serology, or virus isolation.
Treatment: No specific antiviral exists. Management is supportive (rehydration and symptom relief).
High-Risk Populations
Increased susceptibility and severity are observed in:
- Pregnant women & Neonates
- Immunocompromised individuals
- Laboratory & Rodent-control workers
03 Prevention and Control
🛡️
The cornerstone of prevention is rodent control. Maintaining rigorous environmental hygiene and minimizing contact with rodent excreta are essential for both domestic and laboratory safety.
Biofargo team
